| scholarly article | Q13442814 |
| P50 | author | P. Michael Conn | Q86834133 |
| P2093 | author name string | Alfredo Ulloa-Aguirre | |
| James A Dias | |||
| Patricia Casas-González | |||
| Teresa Zariñán | |||
| Guadalupe Maya-Núñez | |||
| Marco A Perez-Solís | |||
| P2860 | cites work | Heterodimerization is required for the formation of a functional GABA(B) receptor | Q22008591 |
| APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex | Q24306372 | ||
| Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor | Q24323205 | ||
| Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties | Q24338580 | ||
| Crystal structure of the ligand-free G-protein-coupled receptor opsin | Q27650885 | ||
| Crystal structure of opsin in its G-protein-interacting conformation | Q27652301 | ||
| Oligomerization of the yeast alpha-factor receptor: implications for dominant negative effects of mutant receptors | Q27929513 | ||
| The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells | Q28207684 | ||
| Inhibition of human type i gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment | Q28239219 | ||
| Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking | Q28245383 | ||
| The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology* | Q28257431 | ||
| Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype | Q28581141 | ||
| Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activation | Q28611068 | ||
| A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of and Opioid Receptor Hetero-oligomers | Q30053100 | ||
| Molecular, structural, and cellular biology of follitropin and follitropin receptor. | Q30329979 | ||
| Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors | Q31136790 | ||
| Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32 | Q34448190 | ||
| GABA(B)-receptor subtypes assemble into functional heteromeric complexes. | Q34485514 | ||
| Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization | Q34643961 | ||
| Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing | Q35040371 | ||
| Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression | Q35610317 | ||
| A molecular dissection of the glycoprotein hormone receptors. | Q35683443 | ||
| Regulation of G protein-coupled receptor export trafficking. | Q35827970 | ||
| Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease | Q35915771 | ||
| Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation | Q36062581 | ||
| Ligand-selective determinants in gonadotropin receptors | Q36630365 | ||
| G protein-coupled receptor dimerisation: molecular basis and relevance to function | Q36636727 | ||
| International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. | Q36747895 | ||
| A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization | Q36983708 | ||
| Multiple facets of follicle-stimulating hormone receptor function. | Q37075995 | ||
| Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions | Q37098373 | ||
| Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization | Q37134357 | ||
| G protein-coupled receptor dimers: functional consequences, disease states and drug targets | Q37166380 | ||
| Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors | Q37455434 | ||
| Identification of amino acids in the C-terminal region of human follicle-stimulating hormone (FSH) beta-subunit involved in binding to human FSH receptor | Q38304668 | ||
| Selective modulation of wild type receptor functions by mutants of G-protein-coupled receptors | Q38325682 | ||
| Functional and structural roles of conserved cysteine residues in the carboxyl-terminal domain of the follicle-stimulating hormone receptor in human embryonic kidney 293 cells. | Q40024382 | ||
| Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles | Q40110422 | ||
| The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function | Q40183639 | ||
| The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities | Q40411565 | ||
| Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor | Q40530994 | ||
| Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting | Q40553552 | ||
| A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface | Q40559858 | ||
| A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor | Q40576741 | ||
| Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor | Q40620754 | ||
| D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. | Q40634567 | ||
| Point mutations in follitropin receptor result in ER retention | Q40653526 | ||
| The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis | Q40817426 | ||
| Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression | Q40824183 | ||
| The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors | Q40853344 | ||
| GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. | Q40984747 | ||
| Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action. | Q41166538 | ||
| Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone | Q41176936 | ||
| A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. | Q41186190 | ||
| Dopamine D2 receptor dimers and receptor-blocking peptides | Q42063592 | ||
| Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans | Q42169860 | ||
| Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function | Q42687550 | ||
| D2/D3 dopamine receptor heterodimers exhibit unique functional properties | Q43617477 | ||
| Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner | Q43733620 | ||
| Biochemical analyses of proteolytic nicking of the human glycoprotein hormone alpha-subunit and its effect on conformational epitopes | Q44357921 | ||
| The CCT promoter directs high-level transgene expression in distal lung epithelial cell lines | Q44493303 | ||
| Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect | Q44856982 | ||
| Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). | Q44861533 | ||
| Follicle Stimulating Hormone (FSH) Activates the p38 Mitogen-Activated Protein Kinase Pathway, Inducing Small Heat Shock Protein Phosphorylation and Cell Rounding in Immature Rat Ovarian Granulosa Cells | Q47914115 | ||
| Use of lithium ion in measurement of stimulated pituitary inositol phospholipid turnover | Q48250869 | ||
| Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. | Q53845537 | ||
| Follicle-Stimulating Hormone (FSH) Stimulates Phosphorylation and Activation of Protein Kinase B (PKB/Akt) and Serum and Glucocorticoid-Induced Kinase (Sgk): Evidence for A Kinase-Independent Signaling by FSH in Granulosa Cells | Q58055435 | ||
| Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure | Q67845721 | ||
| Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the beta-adrenergic receptor | Q67914000 | ||
| Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5'-monophosphates in porcine granulosa cells | Q71501800 | ||
| Different alpha 1-adrenergic receptor sequences required for activating different G alpha subunits of Gq class of G proteins | Q72191113 | ||
| p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation | Q73731244 | ||
| Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell | Q73910547 | ||
| Structure-function relationship of follicle-stimulating hormone and its receptor | Q77313709 | ||
| The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor | Q79340098 | ||
| In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles | Q81434339 | ||
| A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding | Q82309394 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 112-122 | |
| P577 | publication date | 2010-03-04 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys | |
| P478 | volume | 321 |
| Q24337429 | Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3τ interaction domain with a canonical G-protein interaction site |
| Q42290488 | First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome |
| Q33810850 | Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH |
| Q37849545 | Impact of follicle stimulating hormone receptor variants in fertility |
| Q47612221 | Intracellular Trafficking of Gonadotropin Receptors in Health and Disease |
| Q37351126 | Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function. |
| Q35606973 | Pharmacological Chaperones for Misfolded Gonadotropin-Releasing Hormone Receptors |
| Q38429483 | Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias. |
| Q47635965 | Pharmacoperones for Misfolded Gonadotropin Receptors |
| Q26992276 | Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors |
| Q26800024 | Role of the Extracellular and Intracellular Loops of Follicle-Stimulating Hormone Receptor in Its Function |
| Q36277265 | Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor. |
| Q59800376 | Structure-Function Relationships of the Follicle-Stimulating Hormone Receptor |
| Q38887428 | The Follitropin Receptor: Matching Structure and Function |
| Q35855537 | Trafficking of the follitropin receptor |
| Q33717398 | Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens. |
| Q92090915 | Tyrosine nitrations impaired intracellular trafficking of FSHR to the cell surface and FSH-induced Akt-FoxO3a signaling in human granulosa cells |
Search more.